AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 142 filers reported holding AMNEAL PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.34 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $86,579,000 | +4.3% | 16,213,367 | 0.0% | 0.86% | +45.1% |
Q2 2021 | $83,012,000 | -23.9% | 16,213,367 | 0.0% | 0.59% | -53.5% |
Q1 2021 | $109,116,000 | +47.3% | 16,213,367 | 0.0% | 1.27% | +55.1% |
Q4 2020 | $74,095,000 | +17.8% | 16,213,367 | 0.0% | 0.82% | -27.2% |
Q3 2020 | $62,908,000 | -18.5% | 16,213,367 | 0.0% | 1.13% | -17.3% |
Q2 2020 | $77,176,000 | +36.8% | 16,213,367 | 0.0% | 1.36% | +4.8% |
Q1 2020 | $56,423,000 | -27.8% | 16,213,367 | 0.0% | 1.30% | +12.8% |
Q4 2019 | $78,148,000 | -16.9% | 16,213,367 | -50.0% | 1.15% | +65.8% |
Q3 2019 | $94,038,000 | +237.6% | 32,426,734 | +734.8% | 0.70% | +65.9% |
Q2 2019 | $27,853,000 | -49.4% | 3,884,600 | 0.0% | 0.42% | -61.3% |
Q1 2019 | $55,045,000 | +4.7% | 3,884,600 | 0.0% | 1.08% | +27.4% |
Q4 2018 | $52,559,000 | -39.0% | 3,884,600 | 0.0% | 0.85% | -22.5% |
Q3 2018 | $86,199,000 | +27.8% | 3,884,600 | -5.5% | 1.10% | +24.0% |
Q2 2018 | $67,438,000 | – | 4,109,589 | – | 0.88% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Fosun International Ltd | 21,521,301 | $83,503,000 | 7.34% |
Eversept Partners, LP | 2,656,208 | $10,306,087 | 2.29% |
TPG Group Holdings (SBS) Advisors, Inc. | 16,213,367 | $62,908,000 | 1.13% |
Prosight Management, LP | 512,659 | $1,989,000 | 0.95% |
THB ASSET MANAGEMENT | 833,104 | $3,232,000 | 0.90% |
GLOBEFLEX CAPITAL L P | 251,696 | $977,000 | 0.26% |
XTX MARKETS LLC | 10,243 | $40,000 | 0.19% |
HUSSMAN STRATEGIC ADVISORS, INC. | 102,000 | $396,000 | 0.10% |
PA Capital LLC | 33,874 | $132,000 | 0.09% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 60,900 | $236,000 | 0.07% |